Literature DB >> 12367736

A highly sensitive chemiluminescent reverse transcriptase assay for human immunodeficiency virus.

Fumitomo Odawara1, Hideki Abe, Takehiro Kohno, Youko Nagai-Fujii, Kenji Arai, Shigeyuki Imamura, Hideo Misaki, Hiroshi Azuma, Kenji Ikebuchi, Hisami Ikeda, Sharad Mohan, Kouichi Sano.   

Abstract

A simple and highly sensitive reverse transcriptase (RT) assay was developed by combining a previously reported non-radioisotopic RT assay with the use of a template-primer-immobilized microplate, an enzyme capture protocol, product digestion and a chemiluminescent substrate. The assay was able to detect directly the RT activity in serum samples, plasma and cell culture medium without the need for concentration and extraction of the enzyme. The assay was able to detect RT activity equivalent to 100 virions/ml of HIV-1. These results suggest that this highly sensitive chemiluminescent RT assay can be used not only for virological investigation but also for routine screening of biopharmaceuticals.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12367736     DOI: 10.1016/s0166-0934(02)00142-8

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  2 in total

1.  A novel non-radioactive assay for HIV-RT (RdDp) based on pyrosequencing for high-throughput drug screening.

Authors:  Chang Zhang; Yang Wu; Yuna Sun; Chuan Hong; Kehui Xiang; Yu Guo; Mark Bartlam; Zhiyong Lou
Journal:  Protein Cell       Date:  2010-02-24       Impact factor: 14.870

2.  FRET-based assay to screen inhibitors of HIV-1 reverse transcriptase and nucleocapsid protein.

Authors:  Kamal K Sharma; Frédéric Przybilla; Tobias Restle; Julien Godet; Yves Mély
Journal:  Nucleic Acids Res       Date:  2016-01-13       Impact factor: 16.971

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.